Viewing Study NCT01838434


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2025-12-27 @ 11:55 PM
Study NCT ID: NCT01838434
Status: COMPLETED
Last Update Posted: 2018-01-30
First Post: 2013-04-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module